Please wait...

Learn

Finding accredited CPD

Atopic Dermatitis: The new frontier

Description

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease characterised primarily by a cutaneous barrier deficiency and mediated by cutaneous inflammation. The disease has a significant negative impact on patients’ mental and physical functioning, especially due to its chronic, unremitting time course and associated sleep deprivation from pruritus.

This module highlights recent progress in the understanding of the inflammatory pathways involved in AD impacting on treatment of the severe presentations of this condition.

This MJA narrative review shares more.

 


Details

  1. Recognise and treats AD as a chronic disease that has a considerable negative impact on the quality of life of patients and their families
  2. Gain knowledge of the various topical therapies, and selects an optimal treatment plan for the patient
  3. Develop an understanding of the immune pathogenesis of AD, including the role of T helper cells and the inflammatory pathways involved and new targeted immunotherapies

 

Authors: Victoria R Harris, Alan J Cooper

Article Type: Narrative review

 

CPD Activity Details
Provider
Domain
Educational Activities
Type
General Learning
Activity
Professional reading
CPD Hours
1h : 0m
Topic
Pharmaceutical Preparations, Immune System Diseases
Audience
Medical practitioners
Applicable CAPE Aspects
_
Effective Year

You have to log in to see the content of this module.


Provided by


Accredited by

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)